Due to frequent application of CP, cancer cells have obtained resistance to this chemotherapeutic agent, and if an effective cancer chemotherapy is performed, molecular pathways and mechanisms responsible for CP resistance should be identified so they can be targeted through novel therapeutics. The gene discussed is CP; the disease is cancer.